Specialty Pharmacy

Officials with the FDA have approved Alkermes' aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults.

An investigational anti-cancer vaccine will be paired with nivolumab to determine whether the combination therapy will improve survival in patients with the disease.

The device, Pulmonx’s Zephyr Endobronchial Valve (Zephyr Valve) is a less invasive treatment than options currently available to patients.

Top news of the day from across the health care landscape.

Two recent clinical trials evaluated the efficacy of the drug ozanimod, an investigational drug for the treatment of relapsing multiple sclerosis.

Top news of the week from Specialty Pharmacy Times.

Ophthalmic compounding and dispensing can be an expensive and highly technical task.

Glasdegib, in addition to chemotherapy, offers an additional treatment option for patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

Top news of the day from across the health care landscape.

A look at last week's top stories in the world of pharmacy.

The study emphasizes the need for harm reduction interventions that include access to syringes and sterile injection equipment, in addition to comprehensive HIV prevention services.

How changes related to Brexit may influence regulatory, research, and economic perspectives, as well as human health.

The massive online retailer is entering the online pharmacy world with its acquisition of PillPack.

Patients with melanoma who were treated with a combination of radiosurgery and anti-PD-1 immunotherapy experienced better outcomes compared with patients who received anti-CTLA4 immunotherapy.

Top news of the day from across the health care landscape

REMOXY ER is an abuse-deterrent, oral formulation of the widely prescribed opioid medication oxycodone.

Encorafenib (Braftovi) and binimetinib (Mektovi) is now available for patients with advanced BRAF-mutant melanoma.

Researchers identified a trend in which higher body mass index was associated with lower breast cancer risk in women before menopause.

Although HIV diagnoses have dropped across every population in the United States, African Americans remain disproportionately affected by HIV.

Top news of the day from across the health care landscape

Mortality from opioids may be higher than it appears.

National HIV Testing Day, designated by the CDC, aims to encourage individuals to know their status.

New data demonstrate that evolocumab (Repatha) significantly reduced low-density lipoprotein cholesterol and non-high density lipoprotein cholesterol in patients with type 2 diabetes plus hypercholesterolemia or mixed dyslipidemia.

A novel epigenetic drug can be combined with an existing therapy, venetoclax, to more effectively kill high-risk neuroblastoma cells.

Top news of the day from across the health care landscape

Elotuzumab with pomalidomide and low-dose dexamethasone met its primary endpoint in showing a statistically significant, clinically meaningful improvement in progression-free survival in patients with relapsed/refractory multiple myeloma.

Officials with the FDA have approved plazomicin (Zemdri, Achaogen) for the treatment of adults with complicated urinary tract infections (cUTIs), caused by certain Enterobacteriaceae, in patients with limited or no alternative treatment.

Epidiolex is the first FDA-approved drug that contains an active ingredient derived from marijuana and is the first approved treatment for patients with Dravet syndrome.

Current definitions attempting to summarize specialty pharmacy fall short.

The findings highlight the role of Epstein-Barr virus (EBV) infection in multiple sclerosis pathogenesis and support therapies targeting EBV-infected immune cells.